chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Stress; , racing andpalpitations are not normal stressresponses; Blood pressure was increased; Heart rate was increased; . I was prescribedhydroxyzine for possible anxiety.; Heart felt like it was racing for more than 2 hours; Chest pain primarily in the right side; I was unable to run for exercise as I normally do because I experienced increased pain after a couple of blocks; 2 days after my second dose, Inoticed swelling of lymph nodes in myneck (right side).; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 21Apr2021 at 11:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 at 11:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 07:00, the patient experienced swelling of lymph nodes in neck, right side. About 4 days after second dose, the lymph node swelling decreased some, went to urgent care on April 23. On 25Apr2021, the patient experienced chest pain primarily in the right side, was unable to run for exercise as normally did because she experienced increased pain after a couple of blocks. A normal run for her was 5 miles. On 30Apr2021, the patient experienced around midnight, she was in bed and her heart felt like it was racing for more than 2 hours. 03May2021, the patient experienced racing again, this was during the day and she was under stress, racing and palpitations were not normal stress responses for her. She went to urgent care did an EKG, blood pressure was increased and heart rate was increased. She reported no previous diagnosed anxiety, and also stated that chest pain remained. She continued to experience chest pain on and off as of 27May2021. On 03May2021, the patient underwent EKG and the result was blood pressure was increased and heart rate was increased. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the event anxiety and included treatment with hydroxyzine. Therapeutic measures were taken as a result of the event chest pain and included treatment with naproxen. The clinical outcome of the events chest pain, swelling of lymph nodes in neck, was unable to run for exercise as normally did because she experienced increased pain after a couple of blocks, heart felt like it was racing, stress, palpitations, blood pressure was increased and heart rate was increased was recovered with sequelae.  No follow-up attempts are needed. No further information is expected.
Received the shot Ion Tuesday and waited 15 min before leaving the pharmacy. Most symptoms the next day were typical shot symptoms, muscle aches and under the weather for a couple of days. On Friday morning I rode my bicycle and the same shorts I always wear. I started having ulcers in both my mouth and  external on my vagina later in the day. They were painful. The mouth ulcers have gone away but the vaginal ones are still there as of Sunday.  I am a cyclist and have ridden my bike but have not had these issues in many years. No pain while cycling Friday prior to them appearing.
Arm was barely sore; This is a spontaneous report from a contactable consumer (patient) and other Healthcare professional.  A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3246) 1 via an unspecified route of administration on 27Jan2021 (73-year-old at vaccination) as a Dose 1, single for COVID-19 immunization. Vaccine was not administered at (privacy) facility. The patient's Medical history included redundant colon, IBSC (Irritable bowel syndrome), a little elevated cholesterol, arthritis, right hip replacement, vitamin B12 deficiency while she was in college, low estrogen and progesterone. There were no concomitant medications. The reporter stated that she has had this weakness three other times in her life but every time they found the cause of it. One time she had the Epstein bar virus in 1990s. The she had Vitamin B12 deficiency in college. Then in the early 2000s she had low estrogen and progesterone. Recently they checked her for all of this, and it came back normal. The patient's B12 was fine, and it showed that she had Epstein Bar, but they did a titer (result unknown) and checked to see if she had a current infection, and it came back negative. The patient had not received any other vaccine within 4 weeks of covid-19 vaccination.  The patient was not other adverse events following prior vaccination. On an unknown date in 2021, the patient had experienced arm was barely sore. On an unknown date in 2021, the patient underwent lab test and procedure which included lyme disease: unknown results, nothing has come back that. No investigation assessment was reported. The patient had not visited to emergency room/physician office for resulted events. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Noticed a tiny swelling at injection site on 10/8, marked with a pen. Grew four times larger by 10/9. Took to Urgent care on 10/10 and was given antibiotics for infection.
Information has been received from a physician concerning a 4 month old male who, at "two months old," was vaccinated with an oral dose of Rotateq. It was reported that the patient experienced a very high fever, a rash on the body, and red eyes, Kawasaki's disease. Subsequently the patient was hospitalized. No product quality complaint was involved. No other information was provided. Additional information has been requested.  9/4/07 Reviewed hospital medical records which reveal patient experienced fever, diffuse erythematous maculopapular rash, red eyes, nonpurulent conjunctivitis bilaterally, nonproductive cough, watery diarrhea, decreased oral intake, palmar erythema, red lips w/fissures, red tongue & irritability x 5 days.  Seen in ER x 3 & d/c to home.  Admitted 6/27-6/29/07.  Tx w/IVIG & high dose ASA.  Improved & d/c to home on low dose ASA. FINAL DX: Kawasaki syndrome.  10/19/07 Records faxed to CDC.
No adverse Event; Nurse is not sure which vial administered 60 days ago; This spontaneous case was reported by a nurse and describes the occurrence of CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Nurse is not sure which vial administered 60 days ago) and NO ADVERSE EVENT (No adverse Event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051C22A) for COVID-19 vaccination.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In 2022, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Nurse is not sure which vial administered 60 days ago). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Nurse is not sure which vial administered 60 days ago) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (Nurse is not sure which vial administered 60 days ago).    No concomitant medications was reported.  Reporter states that one of their nurses gave a vaccine about 60 days ago, After 31-AUG-2022, but she placed the wrong label on the record.  No treatment information was provided.   Reporter did not allow further contact
Pt received Moderna #1 today at 1024 in left deltoid. Pt complaining to RN of left deltoid to left cheek numbness/tingling starting at 1050. Pt sitting in vaccination OBS room, in no distress, shortness of breath/wheezing, no facial edema noted, no redness/rash/hives noted, pt denies throat swelling/difficulty swallowing, O2 sat 98%. Bilateral upper extremity with equal strength, no unilateral weakness noted, no lower extremity involvement. pt evaluated. Pt denies worsening of symptoms since onset, reports numbness/tingling to entire left arm up to left neck and cheek coming and going in waves. Pt discharged, instructed to return for worsening symptoms.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 62-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 03Oct2022 at 16:30 as dose 4 (booster), single (Lot number: GJ6665) at the age of 61 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 10Jun2022 as dose 3 (booster), single (Lot number: FM0173), in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 05Mar2021 as dose 1, single (Lot number: EP6955), in left arm and on 26Mar2021 as dose 2, single (Lot number: EP6955), in right arm for covid-19 immunisation. The patient's relevant medical history included: "T2 diabetes" (unspecified if ongoing); "migraines" (unspecified if ongoing); "obesity" (unspecified if ongoing); "high blood pressure" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: MELATONIN, start date: 01Jul2021; TRUBIOTICS ONE A DAY, start date: 01Oct2021; ZOLMITRIPTAN, start date: 06Jul2005. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19. Patient received Paxlovid from 22Sep2023 to 27Sep2023 for the treatment of Covid-19.
I had blood work done May 12,2021 by my heart doctor, Dr. He showed me the test stating my ACB score moved from 8% to 18.l31%, meaning my body is now an absolute risk for having a cardiac event within the next 5 years, because the ability for my body to repair and produce new cells have been compromised. I also saw my primary care doctor, Dr. at Health Center. who informed me my immune system has definitely been compromised.
received improperly stored doses of VARIVAX; No adverse effects reported; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies was provided. On an unknown date, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) lot # R030612, expiration date 21-OCT-2020 ) (strength, exact dose and route of administration were not reported) for prophylaxis. It was reconstituted with properly stored sterile diluent (STERILE DILUENT) (lot # and expiration date not reported). No adverse effects were reported. Administered dose of vaccines experienced the temperature excursion between 15 and 46 Fahrenheit degrees (also reported as between -9 and 8.Celsius degrees; also reported as 17.6 Fahrenheit degrees) for 2 hours. The digital data logger was involved in recording the temperature excursion details. There were no previous excursions reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001755:
pt recv vax 12MAY97 & 20MAY97 pt devel varicella w/a fever & a rash on chest;also exp pain on inspiration hurts to take a deep breath;pt recovered from exp;
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients were vaccinated with a dose of RECOMBIVAX HB (lot number not specified). Route was unknown. The reporter stated that up to 10 patients had received improperly stored vaccines during the time period of 17-SEP-2012 through 02-OCT-2012. Vaccines involved were M-M-R II, VAQTA, RECOMBIVAX HB and GARDASIL. No symptoms were reported. This is one of multiple reports from the same source (other case IDs 1210USA005704, 1210USA009229 and 1210USA009230). Additional information has been requested.
Ringing in his ears/ tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in his ears/ tinnitus) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TINNITUS (Ringing in his ears/ tinnitus). At the time of the report, TINNITUS (Ringing in his ears/ tinnitus) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.
Inflammation chest; Heart palpitations; I am sleeping my heart start raising really bad; Burning up; This is a spontaneous report from a contactable consumer (patient).  A 45-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 12Mar2021 (Lot Number: EN6206) as single dose (at the age of 45) for covid-19 immunisation. Medical history was none. The patient's concomitant medications were not reported. The patient experienced inflammation chest on 09Aug2021, heart palpitations (mainly at night time) on 2021, 'i am sleeping my heart start raising really bad' on 2021, burning up on 2021. The patient underwent lab tests and procedures which included blood test: unknown results on 17Jun2021, heart rate: raising. It was reported that after the vaccine in March the patient had heart palpitations and more heart palpitations in June and currently has a heart monitor due to the palpitations. Has not received the second dose and does not know if she should get it.  It was reported patient had on another Heart monitor because the Cardiologist are saying the other one was not picking up any palpitations. States the other one kept going dead and she had to keep switching batteries. Just got the second heart monitor this past 09Aug. Last week she went to the doctor and they told her she has an Inflammation chest and she took Prednisone for 5 days. She took her last Prednisone on Sunday. Mentions again, she went to the Cardiologist and got a second monitor which is a 30 day monitor and it's more intense. Attempt made to slow caller to clarify details. Again mentions she had sent the Cardiologist a message about her palpitations and they said they didn't see any palpitations, which she guess it wouldn't since the batteries get dead all the time. She is going to wear this for 2 weeks. She works in healthcare remotely and is at home and has to have a medical form that she is supposed to return by 26Aug2021 and she has to have the vaccines done by 15 September or she won't have a job. Has a friend who is a Nurse Practitioner who told her not to get the second shot because she probably won't be here because of the bad reaction to the first one. That's what started the reaction, but it's like the cardiologist are saying it's not a reaction from the Pfizer shot, but she never had this until she received the first dose. After getting it she had to sit for 15 minutes and when she left the employee facility that's when they started. She walked to her car and her heart was beating fast and she was Burning up. The outcome of Heart palpitations was not recovered, of the other events was unknown.
itching in her lower arms; Shortness of breath; This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itching in her lower arms) and DYSPNOEA (Shortness of breath) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 609F21A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy (sulfa antibiotics), Allergy to antibiotic (Z-pak), Asthma (since early 20s Recent change in status: stable with medications except for asthma attack after 2nd dose using Albuterol, Pulmicort.) and Blood pressure high (2 years ago Recent change in status: stable) since 2020. Concomitant products included ALBUTEROL [SALBUTAMOL] and BUDESONIDE (PULMICORT) for Asthma, DILTIAZEM, THIORIDAZINE, ASCORBIC ACID, CALCIUM, MINERALS NOS, RETINOL, TOCOPHERYL ACETATE, VITAMIN B NOS, VITAMINS NOS, ZINC (CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS NOS;ZINC]), IBUPROFEN (ADVIL [IBUPROFEN]), IRON, MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) and CALCIUM CITRATE for an unknown indication.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Jan-2021, the patient experienced PRURITUS (itching in her lower arms) and DYSPNOEA (Shortness of breath). On 07-Jan-2021, PRURITUS (itching in her lower arms) and DYSPNOEA (Shortness of breath) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Patient had no history of COVID-19 infection and no history of Myocarditis or pericarditis. Patient did not receive any other vaccine within 1 month prior to Moderna COVID-19 vaccine.  After 1st dose patient experienced itching in her lower arms and shortness of breath during 1 hour. After 1st booster she experienced again itching and shortness of breath during 10 or 15 minutes.. Patient called her pulmonologist to seek medical care for Adverse events. Cardiac related signs and symptoms: Patient experienced the symptom shortness of breath on 7Jan2021, 4Feb2021, and 3Dec2021 and related with 1st, 2nd and 1st booster dose and resolved. No timeline of symptoms, including Cardiac Lab values cause determined. No history of Myocarditis/pericarditis.   This case was linked to MOD-2022-661757 (Patient Link).
high fever, chills, tenderness at site, nausea, weak, fatigue, fast heart beat, shortness of breath
About 3 weeks after my J&J shot my OCD spiked very significantly and unexpectedly. Lasted about 3-4 weeks.
"Covid Arm"  Swelling, red rash around injection site.  Started on day 2, lasted a few days.  Was almost gone and came back on day 7, still ongoing
vial was initially stored in the refrigerator on 02Feb2022, and dose administered on 07Mar2022 beyond 30-day use; vaccine administered beyond the 30 day use by date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine administered beyond the 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02Feb2022, and dose administered on 07Mar2022 beyond 30-day use) in a 38-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022J21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine administered beyond the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02Feb2022, and dose administered on 07Mar2022 beyond 30-day use). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine administered beyond the 30 day use by date) and PRODUCT STORAGE ERROR (vial was initially stored in the refrigerator on 02Feb2022, and dose administered on 07Mar2022 beyond 30-day use) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug reported. The vial was initially stored in the refrigerator on 02-Feb-2022. Patient received booster 1/2 doses. No temperature excursions reported. No treatment information was provided by the reporter.
developed varicella disease (fever, vesicles) 11 days after administration of the disease
5min post vax pt coughed a lot & vomited a lot of phlegm & mucus, lethargic, wheeze, bradycardia called EMT;Vital signs & resp status only;
Sore arm; Heart racing; Diarrhea; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Fibromyalgia (control that with diet).    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), PALPITATIONS (Heart racing), DIARRHOEA (Diarrhea) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   ? No treatment information was provided. ?
Developed redness, sl swelling and skin colored rash to (L) deltoid after hepatitis A vaccine administered. Improved with hydrocortisone cream and oral BENADRYL.
Vaccine given had expiration date of 3/10/2021. Vaccine was expired when administered. No adverse reaction has been reported by patient. Immunization Program advised that vaccine is still effective and there is no need for re-vaccination.
On January 30, 2021, the day after my first dose, I began to have dizzy spells and lots of equilibrium. I checked my blood pressure, and it was normal. On February 1, 2021, I woke up and the room was spinning, and I blacked out for a few seconds. This did not improve during the day. I saw the doctor the next day. I was given the Epley Maneuver to do for possible crystals and prescribed meclizine. This symptom went away for a while but returns occasionally. I took meclizine and this helped about the third day. I have a well-check with my doctor in February.
loses his sense of smell and taste; loses his sense of smell and taste; This is a spontaneous report from a Pfizer sponsored program  from a contactable consumer (Patient's wife).   A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 14Apr2021 as SINGLE DOSE for covid-19 immunisation. The patient medical history and the concomitant medications were not reported.  The patient previously received first dose of BNT162B2 on 24Mar2021 as SINGLE DOSE for covid-19 immunisation. After second dose, loses his sense of smell and taste. The outcome was unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.